Appropriately, they recommend that clinical phase II III trials are required to establish the benefit of tamoxifen in the management of NMIBC and, as mentioned before, any promising therapies in the disease space warrant further investigation tamoxifen withdrawal symptoms Recent evidence has shown that bretylium may also inhibit the Na, K ATPase by binding to the extracellular